Skip to main content

Table 1 Concordance between genotypic (MTBDRplus assay) and phenotypic (Buddemeyer assay) resistance

From: Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplusassay and their implication for treatment outcomes in patients from Mumbai, India

Sample

INH

RIF

 

% Concordance

kappa

% Concordance

kappa

Onset (n = 88)

86

0.72

94

0.84

5th month (n = 67)

97

0.74

99

0.85

Cumulative (n = 155)

91

0.80

96

0.92

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us